Genetic Engineering & Biotechnology News

DEC 2017

Genetic Engineering & Biotechnology News (GEN) is the world's most widely read biotech publication. It provides the R&D community with critical information on the tools, technologies, and trends that drive the biotech industry.

Issue link: http://gen.epubxp.com/i/909577

Contents of this Issue

Navigation

Page 42 of 69

For Research Use Only. Not for use in diagnostic procedures. © 2017 Integrated DNA Technologies, Inc. All rights reserved. Trademarks contained herein are the property of Integrated DNA Technologies, Inc. or their respective owners. For specifi c trademark and licensing information, see www.idtdna.com/trademarks . See the data at www.idtdna.com/CRISPR-Cas9 . Edit on target. Stay on target. Alt-R ® S.p. HiFi Cas9 Nuclease 3NLS • Achieve increased specifi city with strongly reduced off-target activity • Obtain similar high effi ciency to the market-leading Alt-R S.p. Cas9 Nuclease 3NLS • Deliver the ribonucleoprotein effi ciently by lipofection, electroporation, or microinjection • Avoid the toxicity and innate immune response activation commonly observed with in vitro transcribed Cas9 mRNA and sgRNAs

Articles in this issue

Links on this page

Archives of this issue

view archives of Genetic Engineering & Biotechnology News - DEC 2017